Terms: = Brain cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Prognosis
24 results:
1. Anti-Vascular Endothelial Growth Factor Therapy Abolishes Glioma-Associated Endothelial Cell-Induced Tumor Invasion.
Tang F; Li FP; Huang XT; Wang GH; Wang ZF; Li ZQ
J Mol Neurosci; 2023 Mar; 73(2-3):104-116. PubMed ID: 36653624
[TBL] [Abstract] [Full Text] [Related]
2. Immunotherapy as a New Therapeutic Approach for brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract] [Full Text] [Related]
3. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract] [Full Text] [Related]
4. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract] [Full Text] [Related]
5. Efficiency of CAR-T Therapy for Treatment of Solid Tumor in Clinical Trials: A Meta-Analysis.
Hou B; Tang Y; Li W; Zeng Q; Chang D
Dis Markers; 2019; 2019():3425291. PubMed ID: 30886654
[TBL] [Abstract] [Full Text] [Related]
6. Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancer.
Liu Z; Poiret T; Meng Q; Rao M; von Landenberg A; Schoutrop E; Valentini D; Dodoo E; Peredo-Harvey I; Maeurer M
J Transl Med; 2018 Jul; 16(1):182. PubMed ID: 29970101
[TBL] [Abstract] [Full Text] [Related]
7. The effects of interleukin 2 and rAd-p53 as a treatment for glioblastoma.
Qiao HB; Li J; Lv LJ; Nie BJ; Lu P; Xue F; Zhang ZM
Mol Med Rep; 2018 Mar; 17(3):4853-4859. PubMed ID: 29328445
[TBL] [Abstract] [Full Text] [Related]
8. NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.
Liu Z; Poiret T; Persson O; Meng Q; Rane L; Bartek J; Karbach J; Altmannsberger HM; Illies C; Luo X; Harvey-Peredo I; Jäger E; Dodoo E; Maeurer M
Cancer Immunol Immunother; 2018 Feb; 67(2):237-246. PubMed ID: 29058035
[TBL] [Abstract] [Full Text] [Related]
9. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).
Sasayama T; Tanaka K; Mizowaki T; Nagashima H; Nakamizo S; Tanaka H; Nishihara M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Brain Pathol; 2016 Jul; 26(4):479-87. PubMed ID: 26314692
[TBL] [Abstract] [Full Text] [Related]
11. A reinterpretation of the pathogenesis and cure of cancer according to the psychoneuroimmunological discoveries.
Lissoni P
Methods Mol Biol; 2012; 934():183-92. PubMed ID: 22933147
[TBL] [Abstract] [Full Text] [Related]
12. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.
Avril T; Vauleon E; Hamlat A; Saikali S; Etcheverry A; Delmas C; Diabira S; Mosser J; Quillien V
Brain Pathol; 2012 Mar; 22(2):159-74. PubMed ID: 21790828
[TBL] [Abstract] [Full Text] [Related]
13. [Intravascular lymphomatosis manifesting clinically as subacute encephalopathy].
Tsuji H; Mochiduki A; Hosaka A; Yoshizawa T; Tamaoka A
Rinsho Shinkeigaku; 2008 May; 48(5):328-32. PubMed ID: 18540379
[TBL] [Abstract] [Full Text] [Related]
14. Stem and progenitor cell-mediated tumor selective gene therapy.
Aboody KS; Najbauer J; Danks MK
Gene Ther; 2008 May; 15(10):739-52. PubMed ID: 18369324
[TBL] [Abstract] [Full Text] [Related]
15. [Prognostic factors in patients with small cell lung cancer].
Song LH; Song XR; Zhang XQ; Qi JL; Li XJ; Tian H; Bu B
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646
[TBL] [Abstract] [Full Text] [Related]
16. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK
Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521
[TBL] [Abstract] [Full Text] [Related]
17. Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in mice.
Deshmukh P; Glick RP; Lichtor T; Moser R; Cohen EP
J Neurosurg; 2001 Feb; 94(2):287-92. PubMed ID: 11213967
[TBL] [Abstract] [Full Text] [Related]
18. Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans.
Palù G; Cavaggioni A; Calvi P; Franchin E; Pizzato M; Boschetto R; Parolin C; Chilosi M; Ferrini S; Zanusso A; Colombo F
Gene Ther; 1999 Mar; 6(3):330-7. PubMed ID: 10435083
[TBL] [Abstract] [Full Text] [Related]
19. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract] [Full Text] [Related]
20. [Clinical background and treatment of brain metastasis from renal cell carcinoma].
Sumitomo M; Marumo K; Nakamura K; Tachibana M; Baba S; Murai M
Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):705-11. PubMed ID: 9780655
[TBL] [Abstract] [Full Text] [Related]
[Next]
